STOCK TITAN

Notifications

Limited Time Offer! Get Platinum at the Gold price until January 31, 2026!

Sign up now and unlock all premium features at an incredible discount.

Read more on the Pricing page

[Form 4] Tivic Health Systems, Inc. Insider Trading Activity

Filing Impact
(Low)
Filing Sentiment
(Neutral)
Form Type
4
Rhea-AI Filing Summary

Jennifer Ernst, who is listed as both Chief Executive Officer and a director of Tivic Health Systems, Inc. (TIVC), reported a non-derivative acquisition of 22,541 shares of common stock with a reported price of $0, resulting in total beneficial ownership of 23,247 shares after the transaction. The filing indicates the report was made by a single reporting person and reflects an insider equity grant or transfer rather than a market purchase.

Positive
  • Insider acquisition reported: CEO and director acquired 22,541 common shares, increasing her stake to 23,247 shares, which may align executive and shareholder interests.
Negative
  • None.

Insights

TL;DR: CEO and director received an equity grant increasing her ownership modestly, aligning leadership with shareholder interests.

The reported acquisition appears to be a non-cash equity grant or similar internal issuance given the $0 price, which is a common mechanism to compensate executives or vest previously awarded awards. As both CEO and director, the reporting person’s increased ownership can signal alignment of management incentives with long-term shareholder value. The absolute size—23,247 shares beneficially owned post-transaction—is small to moderate depending on the company’s outstanding share count; the filing provides no percentage ownership, so materiality relative to total shares outstanding cannot be assessed from this document alone.

TL;DR: Non-derivative acquisition at $0 suggests internal grant; impact on float and valuation is likely immaterial without outstanding share context.

The transaction code and $0 price indicate an internal issuance such as vesting of restricted stock or a direct grant rather than an open-market purchase. For investors, the key takeaway is insider ownership modestly increased, which can be viewed positively for alignment but does not on its own imply a material change to capitalization or liquidity. The form discloses post-transaction beneficial ownership of 23,247 shares, but without total shares outstanding or percentage ownership this filing alone cannot quantify dilution or signalling magnitude.

SEC Form 4
FORM 4 UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number: 3235-0287
Estimated average burden
hours per response: 0.5
Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
1. Name and Address of Reporting Person*
Ernst Jennifer

(Last) (First) (Middle)
47685 LAKEVIEW BOULEVARD

(Street)
FREMONT CA 94538

(City) (State) (Zip)
2. Issuer Name and Ticker or Trading Symbol
Tivic Health Systems, Inc. [ TIVC ]
5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
X Director 10% Owner
X Officer (give title below) Other (specify below)
Chief Executive Officer
3. Date of Earliest Transaction (Month/Day/Year)
09/22/2025
4. If Amendment, Date of Original Filed (Month/Day/Year)
6. Individual or Joint/Group Filing (Check Applicable Line)
X Form filed by One Reporting Person
Form filed by More than One Reporting Person
Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3) 2. Transaction Date (Month/Day/Year) 2A. Deemed Execution Date, if any (Month/Day/Year) 3. Transaction Code (Instr. 8) 4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5) 5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4) 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V Amount (A) or (D) Price
Common Stock 09/22/2025 A 22,541 A $0 23,247 D
Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3) 2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (Month/Day/Year) 3A. Deemed Execution Date, if any (Month/Day/Year) 4. Transaction Code (Instr. 8) 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) 6. Date Exercisable and Expiration Date (Month/Day/Year) 7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4) 8. Price of Derivative Security (Instr. 5) 9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V (A) (D) Date Exercisable Expiration Date Title Amount or Number of Shares
Explanation of Responses:
/s/ Jennifer Ernst 09/24/2025
** Signature of Reporting Person Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

What did the TIVC filing report about insider activity?

The filing reports that Jennifer Ernst, CEO and director, acquired 22,541 shares of common stock, resulting in 23,247 shares beneficially owned after the transaction.

Was the TIVC transaction a market purchase?

No. The reported price is $0, indicating an internal issuance such as a grant or vesting event rather than an open-market purchase.

Does the Form 4 show the percentage ownership after the transaction for TIVC?

No. The Form 4 shows the number of shares beneficially owned (23,247) but does not provide percentage ownership or total shares outstanding.

Who filed the Form 4 for TIVC?

The form was filed by a single reporting person, identified as Jennifer Ernst, the company’s CEO and a director.

Does this Form 4 indicate any derivative transactions for TIVC?

No. Table II for derivative securities shows no entries; only a non-derivative common stock acquisition is reported.
Tivic Health Systems Inc

NASDAQ:TIVC

TIVC Rankings

TIVC Latest News

TIVC Latest SEC Filings

TIVC Stock Data

3.78M
1.56M
7.15%
2.86%
6.23%
Medical Devices
Electromedical & Electrotherapeutic Apparatus
Link
United States
FREMONT